Bill Allows Medicare to Negotiate Lower Drug Prices and Caps Out-of-Pocket Spending on Medications for Seniors HARRISBURG, Pa., Aug. 12, 2022 /PRNewswire/ — Earlier today the House voted to pass the Inflation Reduction Act of […]
Amgen is the latest pharma company to appear on the radar of Senate Finance Committee Chair Ron Wyden (D-OR), who is investigating the way pharma companies are using subsidiaries in low- or zero-tax countries to […]
They described more difficult working conditions, staff cuts and low pay, as well as difficulties in providing the needed care to the vulnerable residents of the skilled-nurisng facilities. Click here to view original post
Rushdie, 75, was about to speak at the Chautauqua Institution when, at about 11 a.m., a man rushed on stage and attacked Rushdie and an unidentified interviewer. Click here to view original post
As Seagen awaits a final buyout offer from Merck that could be in the territory of $40 billion, Seagen revealed Friday afternoon that it lost an arbitration dispute with Daiichi Sankyo relating to the companies’ […]
Pfizer, which competes with Merck in this market, plans to ask the FDA for an expanded approval of its 20-valent shot later this year. Click here to view original post
After controversially spinning out its talc liabilities and filing for bankruptcy in an attempt to settle 38,000 lawsuits, Johnson & Johnson is now changing up the formula for its baby powder products. J&J is beginning […]
AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate Enhertu scored its second approval in less than a week, this time for a subset of lung cancer patients. Enhertu received accelerated approval on Thursday to treat adults with […]
A Philadelphia biotechnology company gets orphan drug status for its new drug candidate. Click here to view original post
Delaware County went to court to block Crozer Health from temporarily suspending behavioral health programs. Click here to view original post
Copyright © 2022 Biotech Networks, LLC
